Synthesis of XMRV Peptides

To develop a mass spectrometry method that can be used to identify and quantify a novel protein produced by the prostate-cancer-associated retrovirus XMRV in patient samples.
Funding Partners:
  • Edinburgh Napier University
  • Emory University School of Medicine
  • Lypro Biosciences, Inc.
  • The Children's Hospital of Philadelphia
  • University of Maryland, Baltimore
  • University of Louisville
  • Global Blood Therapeutics, Inc.
Program Partners:
  • CDC's National Center for Emerging and Zoonotic Infectious Diseases
Program Location:
  • United States of America